Tubao Yang

Tubao Yang

Auto-generated profile, based on publicly available information

Tubao Yang

Department of Epidemiology and Health Statistics, School of Public Health, Central South University, Changsha, Hunan Province 410008, China

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JQJia-Bi Qin
Jia-Bi Qin
TYTubao Yang
Tubao Yang
SXShuiyuan Xiao
Shuiyuan Xiao
HTHongzhuan Tan
Hongzhuan Tan
TFTiejian Feng
Tiejian Feng
HFHanlin Fu
Hanlin Fu
To estimate probability of adverse pregnancy outcomes (APOs) among women with and without syphilis through a systematic review of published literatures. Chinese and English literatures were searched for studies assessing pregnancy outcomes in the presence of maternal syphilis through August 2013. The prevalence estimates were summarized and analyzed by meta-analysis. Fifty-four literatures involving 11398 syphilitic women and 43342 non-syphilitic women were included from 4187 records initially found. Among untreated mothers with syphilis, pooled estimates were 76.8% for all APOs, 36.0% for congenital syphilis, 23.2% for preterm, 23.4% for low birth weight, 26.4% for stillbirth or fetal loss, 14.9% for miscarriage and 16.2% for neonatal deaths. Among syphilitic mother receiving treatment only in the late trimester (>28 weeks), pooled estimates were 64.4% for APOs, 40.6% for congenital syphilis, 17.6% for preterm, 12.4% for low birth weight, and 21.3% for stillbirth or fetal loss. Among syphilitic mothers with high titers (≥1∶8), pooled estimates were 42.8% for all APOs, 25.8% for congenital syphilis, 15.1% for preterm, 9.4% for low birth weight, 14.6% for stillbirth or fetal loss and 16.0% for neonatal deaths. Among non-syphilitic mothers, the pooled estimates were 13.7% for all APOs, 7.2% for preterm birth, 4.5% for low birth weight, 3.7% for stillbirth or fetal loss, 2.3% for miscarriage and 2.0% for neonatal death. Begg's rank correlation test indicated little evidence of publication bias (P>0.10). Substantial heterogeneity was found across studies in the estimates of all adverse outcomes for both women with syphilis (I2 = 93.9%; P<0.0001) and women without syphilis (I2 = 94.8%; P<0.0001). Syphilis continues to be an important cause of substantial perinatal morbidity and mortality, which reminds that policy-makers charged with resource allocation that the elimination of mother-to-child transmission of syphilis is a public health priority.

1 October 2015 in The Knee
Verified
Journal Article
Closed access
JWJie Wei
Jie Wei
HYHao-Bin Yang
Hao-Bin Yang
JQJia-Bi Qin
Jia-Bi Qin
TYTu-Bao Yang
Tu-Bao Yang

1 February 2015
Verified
Journal Article
Open access
JQJia-Bi Qin
Jia-Bi Qin
TYTubao Yang
Tubao Yang
HWHua Wang
Hua Wang
TFTiejian Feng
Tiejian Feng
XLXiaoying Liu
Xiaoying Liu
Background: Several studies have been conducted in China in order to investigate the potential predictors of serofast state after treatment among syphilitic patients. However, there is a remarkable diversity among the results. This meta-analysis was conducted to assess potential predictors of serofast among syphilitic patients in China. Methods: International and national electronic databases were searched up to September 2013. Reference lists of retrieved articles were also reviewed. Cohort or case-control studies addressing risk factors of serofast among syphilitic patients were included in this study. Results: We assessed 27 separate studies involving overall 6682 HIV-negative participants with syphilis of which 1962 remained in the serofast state. The serofast was positively associated with older age(P-trend=0.001), female(summary risk ratio[sRR]=1.50, 95% CI: 1.34-1.68), latent syphilis(sRR(latent vs primary)=3.17, 95% CI: 2.66-3.77; sRR(latent vs secondary)=2.00, 95% CI: 1.48-2.69) as well as non-penicillin treatment(sRR =2.99, 95% CI: 2.45-3.67), but negatively associated with higher baseline titers(sRR(>1. 32 vs <= 1.32)=0.63, 95% CI: 0.54-0.75). Compared with healthy group and serological cure group, respectively, the levels of CD4 (+), IL-2, and IL-6 among serofast patients were decreased (standardized mean difference[SMD]<0, P0, P<0.05). Some studies also hinted the serofast was associated with subtypes i of treponema pallidum(TP) repeat gene (RRivs d=4.67,95% CI: 1.31-6.69) and TP occult infection. Conclusion: The age, gender, stage of infection, baseline titers, treatment drug, cellular immune suppression and disorders, TP occult infection and subtypes i of TP repeat gene should be considered as important predictors of serofast. However, until now the definition and mechanism of serofast has still been not clear.

1 February 2013 in Australian and New Zealand Journal of Public Health
Verified
Journal Article
Closed access
PDF file
JQJiabi Qin
Jiabi Qin
TYTubao Yang
Tubao Yang
FKFanjing Kong
Fanjing Kong
JWJie Wei
Jie Wei
XSXuzhen Shan
Xuzhen Shan

1 November 2006 in Chinese Medical Journal
Verified
Journal Article
Open access
TYTu-Bao Yang
Tu-Bao Yang
FZFu-Hua Zeng
Fu-Hua Zeng
ZSZhen-Qiu Sun
Zhen-Qiu Sun
Previous studies showed that the prognostic factors for superficial transitional cell carcinoma of the bladder varied with the findings of different cohorts. Few multivariate analyses of prognostic factors for superficial bladder tumors have been reported in China and bladder preservation as a prognostic index of superficial bladder tumors is limited and scarce in Chinese patients. This study was conducted to analyze a group of risk factors for prognostic outcomes for patients with primary superficial transitional cell carcinoma of the bladder. Between January 1980 to December 2000, 198 patients [172 men and 26 women; mean age (52.98± 11.28) years] with primary superficial transitional cell carcinoma who were pathologically classified as Ta or T1 in Hunan Provincial Tumor Hospital (Changsha, China) were enrolled in this study. Surgical methods included local resection and electric coagulation of bladder tumors, transurethral resection of bladder tumors and partial cystectomy. After initial surgical treatment, patients were followed through a cystoscopy every three months during the first two years and every six months thereafter in the design of retrospective cohort. Survival analysis was performed to analyze risk factors of the prognostic outcomes for transitional cell carcinoma of the bladder. Canonical correlation analysis was conducted to present and interpret synthetically the multi-correlation between all kinds of prognostic outcomes and risk factor in multiply dimensions. The average follow-up period was (6.65±4.74) years. Assessments at three, five, and 10 years showed recurrence rates, respectively, of (28.32±3.45)%, (35.31±3.83)%, and (42.48±4.40)%; progression rates of (8.89±2.14)%, (15.16±2.94)%, and (23.88±4.19)%; bladder-preservation rates of (94.68±1.74)%, (93.87± 1.91)%, and (91.51±2.49)%; metastasis rates of (8.25±2.05)%, (11.24±2.47)%, and (28.94±4.93)%; and cancer-related survival rates of (95.02±1.62)%, (90.70±2.45)%, and (77.14±4.88)%. The main risk factors for recurrence were histological grade, blood transfusion during surgery and the duration of symptoms. Progression was affected by blood transfusion during surgery, histological grade, the number of re-examinations, and the length of the recurrence-free period. Metastasis was associated with tumor multifocality, hydronephrosis, microscopic growth pattern, and the recurrence-free period. Cancer-related survival was influenced by microscopic growth pattern and the recurrence-free period. Bladder preservation involved only the recurrence-free period. The comprehensive results from canonical correlation analysis showed that the main prognostic outcomes were cancer-related survival, metastasis and progression respectively, while the dominate risk factors were histological grade, tumor multifocality and blood transfusion. The risk factors were different for each prognostic outcome of transitional cell carcinoma of the bladder. This is helpful for predicting the prognosis of transitional cell carcinoma of the bladder and designing therapeutic and follow-up strategies for this cancer. Chin Med J2006;119(21):1821–1828